S 771 Massachusetts Senate · 192nd Legislature (2021-2022)

An Act relative to pharmaceutical access, costs and transparency

Summary

By Ms. Friedman, a petition (accompanied by bill, Senate, No. 771) of Cindy F. Friedman, Jason M. Lewis, Joanne M. Comerford, Michael O. Moore and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency. Health Care Financing.

Bill status passed both 4 of 5 stages cleared

Introduction

Mar 2021

Committee Review

Feb 2022

Senate Passage

Feb 2022

House Passage

Mar 2021

Governor

Introduced Mar 29, 2021 Last action Feb 10, 2022

Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.

Full legislative history

Actions timeline

Total actions

10

Key actions

4

Committee

3

Feb 3, 2022

Upper · Passed

Order relative to subject matter adopted

upper

Feb 3, 2022

Upper · Passed

Committee recommended ought to pass with an amendment substituting a new draft, S2651

upper

Nov 17, 2021

Upper · Passed

Bill reported favorably by committee and referred to the committee on Senate Ways and Means

upper

Mar 29, 2021

Lower · Passed

House concurred

lower

Mar 29, 2021

Committee

Referred to the committee on Health Care Financing

upper

1 primary · 11 co-sponsors

Sponsors

Role

Legislator

Party

State

District

Fourth Middlesex

Berkshire, Hampshire, Franklin and Hampden

First Hampden and Hampshire

Fifth Middlesex

Hampshire, Franklin and Worcester

Michelle Ciccolo

Second Worcester

Patrick O'Connor

First Plymouth and Norfolk